Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes

• Yvonne L. Lont,

  Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

  ⨯
• Luc E. Coffeng,

  Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

  ⨯
• Sake J. de Vlas,

  Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

  ⨯
• Allison Golden,

  Affiliation PATH, Seattle, Washington, United States of America

  ⨯
• Tala de los Santos,

  Affiliation PATH, Seattle, Washington, United States of America

  ⨯
• Gonzalo J. Domingo ,

  Contributed equally to this work with: Gonzalo J. Domingo, Wilma A. Stolk

  Affiliation PATH, Seattle, Washington, United States of America

  ⨯
• Wilma A. Stolk

  Contributed equally to this work with: Gonzalo J. Domingo, Wilma A. Stolk

  * E-mail: w.stolk@erasmusmc.nl

  Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

  http://orcid.org/0000-0001-9509-1328

  ⨯